Novartis trades on Xetra, shares track Thursday's analyst and chart cues
25.06.2026 - 15:41:00 | ad-hoc-news.deBy Christina Vogel, Background & Management desk. Reviewed prior to publication on 2026-06-25, 13:40.
Novartis AG (CH0012005267) trades with Switzerland's large-cap healthcare names on the SIX-linked market setup. On Thursday, the stock is framed by the Swiss blue-chip sector and by chart levels that traders can verify on exchange and market data pages. Reuters coverage of Swiss healthcare trading
Thursday chart levels
Novartis shares are best read against the 200-day line and the latest daily range, both standard markers in a Thursday technical check. That setup is relevant for a stock that trades in a defensive sector and often follows broader healthcare rotation.
The Swiss market context also matters because Novartis sits among the country's most widely watched large caps. Sector peers such as Roche and Lonza help frame relative performance when investors compare healthcare names in Zurich.
Consensus and peers
Analyst commentary around Novartis usually comes from large international houses and Swiss brokers, with consensus pages and research notes giving the clearest read on positioning. MarketScreener consensus view for Novartis
For Thursday coverage, the useful comparison is not a forecast but the current setup versus Roche and the broader SMI healthcare basket. That keeps the focus on documented valuations, ratings, and index membership rather than speculation.
All news and analysis on Novartis shares
The Novartis investor page and the ISIN topic page collect company disclosures, market context, and follow-up coverage in one place.
How Novartis makes money
Novartis sells prescription medicines in immunology, oncology, cardiovascular medicine, and neuroscience. Key brands include Kisqali, Cosentyx, Entresto, and Pluvicto, which anchor the company's revenue base in global specialty pharma.
Where the stock trades today
Novartis shares were last quoted at 13:40 UTC on June 25, 2026, on the Swiss market in Swiss francs.
Novartis at a glance
- Company: Novartis AG
- ISIN: CH0012005267
- Ticker: NOVN
- Trading venue: SIX
- Price (as of 2026-06-25, 13:40): unavailable
- Sector / industry: Health Care / Pharmaceuticals
- Index membership: SMI
This article was produced with AI assistance and editorially reviewed. Price and company figures without guarantee; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions carry risks up to and including total loss.
